Ana Elísabet López-Sundh

Dr. Ana Elísabet López-Sundh

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2020 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
José Luis HernándezJosé Luis Hernández
José Luis Hernández
CBCristina Baldeón
Cristina Baldeón
ALAna Elísabet López-Sundh
Ana Elísabet López-Sundh
J. Gonzalo Ocejo-VinyalsJ. Gonzalo Ocejo-Vinyals
J. Gonzalo Ocejo-Vinyals
RBRicardo Blanco
Ricardo Blanco
MGMarcos Antonio González-López
Marcos Antonio González-López
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease associated with several comorbidities and vascular risk factors, such as dyslipidemia. The present study aimed to assess the possible associations between the lipid profile and atherogenic indexes and the severity of HS. Methods: This case-control study enrolled 78 HS patients and 62 healthy controls. Classic lipid profile and lipoprotein ratios, including the atherogenic index of plasma (AIP), were evaluated. The severity of HS was measured by the HS Physician Global Assessment (PGA). Results: HS-patients had lower serum total cholesterol and HDL-C levels and higher AIP than the control group. AIP was positively correlated to BMI, waist circumference, systolic and diastolic blood pressure, LDL-C, triglycerides, non-HDL-C, ApoB, HOMA, and hs-CRP and negatively to HDL-C and ApoA1. For the overall lipid profile, only AIP was related to a more severe HS (PGA ≥ 3) after controlling for age, sex, BMI, insulin resistance (IR), active smoking, and statin use (r = 0.268; p = 0.023). Multiple logistic regression adjusted for age, sex, BMI, IR, smoking status and statin use, showed that AIP ≥ 0.11 was significantly associated with the severity of HS (OR, 4.38; CI 95%, 1.09–17.50; p = 0.037). Conclusions: In conclusion, these results showed that AIP is significantly and independently associated with HS severity.

26 November 2020 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
ALAna Elísabet López-Sundh
Ana Elísabet López-Sundh
AQA. Quintana-Sancho
A. Quintana-Sancho
CDC. Durán-Vian
C. Durán-Vian
LRL. Reguero-DelCura
L. Reguero-DelCura
ACA. F. Corrales-Martínez
A. F. Corrales-Martínez
MGM. A. González-López
M. A. González-López

Verified
Journal Article
Open access
PDF file
Jose RianchoJose Riancho
Jose Riancho
José Luis HernándezJosé Luis Hernández
José Luis Hernández
CGCarmen González-Vela
Carmen González-Vela
ALAna Elísabet López-Sundh
Ana Elísabet López-Sundh
MGMarcos Antonio González-López
Marcos Antonio González-López
EDEli L. Diamond
Eli L. Diamond
Histiocytoses encompass a group of exceptionally rare disorders characterized by the abnormal infiltration of tissues by histocytes. Among these, Erdheim–Chester disease (ECD) stands out as a multisystem histiocytosis that typically affects bones and various other tissues. Historically, the treatment of ECD has been challenging. However, recent breakthroughs in our understanding, particularly the discovery of somatic mutations in the RAS-MAPK pathway, have opened new opportunities for targeted therapy in a significant subset of patients with ECD and other histiocytoses. In this report, we present the case of a patient with ECD harboring a previously unidentified microduplication in the NRAS gene in a small fraction of skin cells. This discovery played a pivotal role in tailoring an effective therapeutic approach involving kinase inhibitors downstream of NRAS. This case underscores the crucial role of deep sequencing of tissue samples in ECD, enabling the delivery of personalized targeted therapy to patients.

26 October 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
ALAna Elísabet López-Sundh
Ana Elísabet López-Sundh
EEEsperanza Escribano‐Palomino
Esperanza Escribano‐Palomino
MFMarta Feito‐Rodríguez
Marta Feito‐Rodríguez
JTJair Tenorio
Jair Tenorio
MBMaría Emilia Brizzi
María Emilia Brizzi
RLRaúl de Lucas‐Laguna
Raúl de Lucas‐Laguna

1 September 2021 in Journal of Paediatrics and Child Health
Verified
Journal Article
Open access
PDF file
ALAna Elísabet López-Sundh
Ana Elísabet López-Sundh
CGCristina Gómez‐Fernández
Cristina Gómez‐Fernández
PMPablo Marlasca‐SanMartín
Pablo Marlasca‐SanMartín
DPDaniel Pérez‐González
Daniel Pérez‐González
LRLeandra Reguero‐DelCura
Leandra Reguero‐DelCura
MGMarcos A González‐López
Marcos A González‐López
Click on the article title to read more.

27 August 2020 in Research Square
Verified
Preprint
Open access
PDF file
José Luis HernándezJosé Luis Hernández
José Luis Hernández
CBCristina Baldeón
Cristina Baldeón
ALAna Elísabet López-Sundh
Ana Elísabet López-Sundh
J. Gonzalo Ocejo-VinyalsJ. Gonzalo Ocejo-Vinyals
J. Gonzalo Ocejo-Vinyals
RBRicardo Blanco
Ricardo Blanco
MGMarcos Antonio González-López
Marcos Antonio González-López
Background. Hidradenitis suppurativa (HS) is a chronic inflammatory disease associated with several comorbidities and vascular risk factors, such as dyslipidemia. The present study aimed to assess the possible associations between the lipid profile and atherogenic indexes and the severity of HS. Methods . This case-control study enrolled 78 HS patients and 62 healthy controls. Classic lipid profile and lipoprotein ratios, including the atherogenic index of plasma (AIP), were evaluated. The severity of HS was measured by the HS Physician Global Assessment (PGA). Results . HS-patients had lower serum total cholesterol and HDL-C levels and higher AIP than the control group. AIP was positively correlated to BMI, waist circumference, systolic and diastolic blood pressure, LDL-C, triglycerides, non-HDL-C, ApoB, HOMA, and hs-CRP and negatively to HDL-C and ApoA1. For the overall lipid profile, only AIP was related to a more severe HS (PGA≥3) after controlling for age, sex, BMI, insulin resistance (IR), active smoking, and statin use (r=0.268; p=0.023). Multiple logistic regression adjusted for age, sex, BMI, IR, smoking status and statin use, showed that AIP≥0.11 was significantly associated with the severity of HS (OR, 4.38; CI 95%, 1.09-17.50; p=0.037). Conclusions . In conclusion, these results showed that AIP is significantly and independently associated with HS severity.